Lower dose hormone replacement therapy just as effective as often prescribed doses

June 03, 2001

CHARLOTTESVILLE, Va., June 4 - Lower doses of hormone replacement therapy (HRT) are just as effective at reducing hot flashes and vaginal changes in postmenopausal women as currently prescribed doses, according to a study published in the June issue of Fertility and Sterility.

The Women's Health, Osteoporosis, Progestin, and Estrogen (HOPE) study, in which the University of Virginia Health System participated as a site, found that lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone (MPA), an agent that protects the uterus against cancer, improve symptoms of menopause as effectively as commonly prescribed doses.

"This is exciting research," said Dr. JoAnn Pinkerton, director of the U.Va. Health System MidLife Center and coauthor of the HOPE study. "The results confirm the safety and efficacy of lower doses of estrogen. Women entering menopause will have the option of lower doses, which in this study were proven effective at relieving hot flushes and vaginal changes. The availability of lower doses should ease the fears of those who are concerned about the link between estrogen and breast cancer." The double-blind study involved more than 2,000 healthy, postmenopausal women with intact uteruses. A group of 243 symptomatic women were measured by the number and severity of their hot flashes and their vaginal maturation index (VMI), which assesses vaginal changes.

The women were instructed to take two tablets - one was CEE or matching placebo, the other was a mixture of CEE and MPA.

After one year researchers found that the women taking .45 milligrams of CEE and 1.5 milligrams of MPA, and .3 milligrams of CEE and 1.5 milligrams of MPA had reduced numbers of hot flashes and vaginal changes, which were comparable to the currently prescribed dose of .625 milligrams of CEE and 2.5 to 5 milligrams of MPA.

Breast pain was found to be the most common side effect of the lower dose estrogen regimen. Importantly, however, less bleeding was found with the lower doses. Bleeding is a major reason why women discontinue HRT, Pinkerton said.
-end-
The HOPE clinical trials were supported by funds from Wyeth Laboratories. "The Food and Drug Administration is expected to approve a low dose HRT by the end of the summer," Pinkerton said.

Ketchum DC

Related Estrogen Articles from Brightsurf:

Removal of synthetic estrogen from water
Synthetic estrogens from pharmaceuticals contaminate rivers and threaten the health of humans and fish.

Does estrogen influence alcohol use disorder?
A new study from researchers at the University of Illinois at Chicago shows that high estrogen levels may make alcohol more rewarding to female mice.

Estrogen's role in the sex differences of alcohol abuse
Fluctuating estrogen levels may make alcohol more rewarding to female mice, according to new research in JNeurosci.

Estrogen's opposing effects on mammary tumors in dogs
Estrogen's role in canine mammary cancer is more complex than previously understood, according to new research led by the University of Pennsylvania School of Veterinary Medicine.

Placenta transit of an environmental estrogen
The human foetus is considered to be particularly sensitive to environmental contaminants.

Estrogen improves Parkinson's disease symptoms
Brain-selective estrogen treatment improves the symptoms of Parkinson's disease in male mice, according to new research published in JNeurosci.

The sneaky way estrogen drives brain metastasis in non-estrogen-dependent breast cancers
University of Colorado Cancer Center study shows that while estrogen doesn't directly affect triple-negative breast cancer cells, it can affect surrounding brain cells in ways that promote cancer cell migration and invasiveness

New study demonstrates effectiveness and safety of vaginal estrogen
Despite its proven effectiveness in treating the genital symptoms of menopause, low-dose vaginal estrogen therapy remains underused largely because of misperceptions regarding its safety.

Hidden estrogen receptors in the breast epithelium
EPFL scientists have uncovered that next to estrogen receptor positive and negative there are cells with very low amounts of the receptor protein.

Estrogen may protect against depression after heart attack
Estrogen may protect against heart failure-related depression by preventing the production of inflammation-causing chemicals in the brain.

Read More: Estrogen News and Estrogen Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.